Director/PDMR Shareholding
Updated : 16:53
13 October 2022
Coral Products plc
(the "Company", the "Group" or "Coral")
PDMR/Director Dealings
Coral Products plc (AIM: CRU), a specialist in the design, manufacture and supply of plastic products, announces that it was informed on 12 October 2022 of the following purchase by Paul Freud, Corporate Development Director of the Company:
Director/PCA | Purchase price | Number of shares purchased | Resultant beneficial share holdings | Resultant percentage of beneficial share holdings |
Paul Freud | 14.3 pence | 46,400 | 2,344,733 | 2.79% |
For further information, please contact:
Coral Products plc Joe Grimmond, Chairman
|
Tel: 07703 518 148
|
Nominated Adviser & Broker Cenkos LLP Stephen Keys Charlie Combe |
Tel: 020 7397 1966 |
Financial PR Novella Tim Robertson | Tel: 020 3151 7008 |
The information in the below notification is disclosed in accordance with Article 19 of the EU Market Abuse Regulation.
1 | Details of PDMR/person closely associated with them ("PCA") | |||||
1.1 | Name | Paul Freud | ||||
1.2 | Position/Status | Corporate Development Director | ||||
1.3 | Initial notification / amendment | Initial notification | ||||
2 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
2.1 | Name | Coral Products plc | ||||
2.2 | LEI | 213800M2XLY2QGBMUN82 | ||||
3 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
3.1 | Description of the financial instrument Identification code | Ordinary shares of 1.0 pence each
| ||||
3.2 | Nature of the transaction | Purchase of Ordinary Shares | ||||
3.3 | Price(s) and volume(s) |
| ||||
3.4 | Aggregated information ·Aggregated volume · Price |
N/a N/a | ||||
3.5 | Date of the transaction | 12th October 2022 | ||||
3.6 | Place of the transaction | London Stock Exchange (AIM:CRU) | ||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.